Gastroenterology

Dr Raine described corticosteroids as the first IBD drugs to undergo clinical trials. A seminal study, one of the first to introduce the concept…

Over the past years, the conceptual framework behind the pathogenesis of IBD has come into sharper focus. In healthy individuals, the intestinal…

UC is a chronic, progressive disorder with an unknown aetiology.1 Few population-based cohort studies have assessed both disease course and the use…

CRC is the third most common form of cancer globally, with 1.8 million new cases diagnosed every year…

Nonalcoholic fatty liver disease (NAFLD) has become an emerging disease throughout the world. Metabolic comorbidities such as obesity…

Prof Panaccione believed that biologic therapies are generally underutilised in patients with IBD; they are started too late and prescribed to too few…

Europe has the leading prevalence rates of inflammatory bowel diseases (IBD) in the world. It is estimated that 2.5–3.0 million people on the continent bear the condition,1 and the associated costs are on the rise…

Gastroesophageal reflux disease (GERD) is a common gastrointestinal (GI) disorder worldwide. Proton pump inhibitors (PPI) are the mainstay of treatment…